Financials ImExHS Limited

Equities

IME

AU0000023053

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 22:57:57 2024-05-12 EDT			5-day change	1st Jan Change
0.5 ^AUD	0.00%		0.00%	-25.37%

04-25	IMEXHS Completes AU$250,000 Conditional Placement	MT
03-22	IMEXHS Renews Two Enterprise Software Contracts; Shares Up 3%	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	44.67	47.82	34.01	18.98	28.55	22.77	-	-
Enterprise Value (EV) ¹	44.67	38.72	32.19	18.18	28.55	20.28	14.86	6.73
P/E ratio	-6.33 x	-	-6.8 x	-5.39 x	-	-	-	-
Yield	-	-	-	-	-	-	-	-
Capitalization / Revenue	5.68 x	4.38 x	2.54 x	1.11 x	1.45 x	0.93 x	0.74 x	0.62 x
EV / Revenue	5.68 x	3.55 x	2.41 x	1.06 x	1.45 x	0.83 x	0.48 x	0.18 x
EV / EBITDA	-	-29.8 x	-10.7 x	-182 x	63.7 x	7.53 x	2.33 x	0.76 x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Price to Book	-	3.08 x	2.04 x	1.19 x	-	1.29 x	0.99 x	0.73 x
Nbr of stocks (in thousands)	23,513	29,700	32,861	41,258	42,608	45,537	-	-
Reference price ²	1.900	1.610	1.035	0.4600	0.6700	0.5000	0.5000	0.5000
Announcement Date	20-02-27	21-02-25	22-02-28	23-02-28	24-02-28	-	-	-

¹AUD in Million²AUD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	7.87	10.91	13.37	17.12	19.67	24.41	30.87	36.55
EBITDA ¹	-	-1.3	-3	-0.1	0.4483	2.693	6.382	8.847
EBIT ¹	-	-2.323	-4.245	-2.497	-1.981	0.4848	4.913	7.821
Operating Margin	-	-21.29%	-31.75%	-14.59%	-10.07%	1.99%	15.92%	21.4%
Earnings before Tax (EBT)	-	-	-4.556	-	-	-	-	-
Net income	-	-	-4.7	-	-	-	-	-
Net margin	-	-	-35.14%	-	-	-	-	-
EPS	-0.3000	-	-0.1522	-0.0854	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-	-
FCF margin	-	-	-	-	-	-	-	-
FCF Conversion (EBITDA)	-	-	-	-	-	-	-	-
FCF Conversion (Net income)	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Announcement Date	20-02-27	21-02-25	22-02-28	23-02-28	24-02-28	-	-	-

¹AUD in Million²AUD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 S1	2023 S1	2023 S2
Net sales ¹	5.233	8.804	10.87
EBITDA ¹	-2.141	0.503	-0.055
EBIT ¹	-2.673	-1.044	-0.9373
Operating Margin	-51.08%	-11.86%	-8.63%
Earnings before Tax (EBT)	-	-	-
Net income	-	-	-
Net margin	-	-	-
EPS	-	-	-
Dividend per Share	-	-	-
Announcement Date	21-08-30	23-08-31	24-02-28

¹AUD in Million

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-	-	-
Net Cash position ¹	-	9.1	1.82	0.79	-	2.49	7.91	16
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow	-	-	-	-	-	-	-	-
ROE (net income / shareholders' equity)	-	-28%	-29.2%	-18.7%	-	5.21%	27.9%	0.32%
ROA (Net income/ Total Assets)	-	-20.3%	-20.2%	-	-	3.68%	20.3%	24.9%
Assets	-	-	23.28	-	-	-	-	-
Book Value Per Share ²	-	0.5200	0.5100	0.3900	-	0.3900	0.5000	0.6900
Cash Flow per Share ²	-	-0.0600	-0.1000	-0.0600	-	0.1100	0.1300	0.1900
Capex ¹	-	1.26	1.01	0.65	-	1.63	1.46	-
Capex / Sales	-	11.59%	7.55%	3.79%	-	6.68%	4.72%	-
Announcement Date	20-02-27	21-02-25	22-02-28	23-02-28	24-02-28	-	-	-

¹AUD in Million²AUD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for ImExHS Limited

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.5 AUD

Average target price

1.5 AUD

Spread / Average Target

+200.00%

Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

	1st Jan change	Capi.
IMEXHS LIMITED	-25.37%	15.04M
VEEVA SYSTEMS INC.	+5.89%	32.95B
PRO MEDICUS LIMITED	+18.09%	7.82B
SECTRA AB	+30.15%	4.17B
EVOLENT HEALTH, INC.	-28.10%	2.72B
OMNICELL, INC.	-18.15%	1.41B
LUNIT INC.	-33.33%	1.15B
SIMULATIONS PLUS, INC.	+9.61%	980M
B-SOFT CO.,LTD.	-37.56%	873M
VERADIGM INC.	-26.41%	831M

Medical Software & Technology Services